ENHANCING TRANSDERMAL DELIVERY OF POORLY WATER-SOLUBLE NSAIDS: EFFECTIVE STRATEGIES
DOI:
https://doi.org/10.22159/ijcpr.2024v16i6.5070Keywords:
Transdermal drug delivery, NSAIDs, Anticomplementary drugs, Poorly water-soluble drugs, Chemical enhancersAbstract
Transdermal drug delivery offers significant advantages for administering non-steroidal anti-inflammatory drugs (NSAIDs) and anti-complementary drugs, particularly those with poor water solubility. This delivery route bypasses first-pass metabolism and gastrointestinal degradation, enhancing bioavailability and patient compliance. However, the stratum corneum, the outermost layer of the skin, poses a formidable barrier to drug permeation. To address this challenge, several innovative strategies have been developed to improve the transdermal delivery of these poorly soluble drugs.
Chemical enhancers, such as alcohols, fatty acids, and surfactants, can disrupt the lipid structure of the stratum corneum, increasing drug solubility and permeability. Nanoformulations, including liposomes, niosomes, solid lipid nanoparticles, and nanoemulsions, enhance drug solubility, provide protection against degradation, and facilitate controlled release with deeper skin penetration. Prodrugs, designed to convert into the active drug within the skin, can improve solubility and permeability. Physical methods like microneedles, iontophoresis, and phonophoresis create micropores or use electrical and ultrasound waves to enhance permeation without compromising skin integrity.
Cyclodextrins form inclusion complexes with drugs, boosting solubility and stability. Hydrogels and polymer-based formulations create a moist environment for sustained drug release and better absorption. Co-solvents and surfactants, such as ethanol and DMSO, further enhance solubility and disrupt the stratum corneum to facilitate drug penetration. Electroporation and thermal ablation transiently disrupt the skin barrier, significantly improving drug permeation.
These strategies, individually or in combination, hold promise for optimizing the transdermal delivery of poorly water-soluble NSAIDs and anticomplementary drugs, ensuring effective therapeutic outcomes and improved patient compliance.
Downloads
References
Dumitriu Buzia O, Paduraru AM, Stefan CS, Dinu M, Cocoș DI, Nwabudike LC. Strategies for improving transdermal administration: new approaches to controlled drug release. Pharmaceutics. 2023 Apr 7;15(4):1183. doi: 10.3390/pharmaceutics15041183, PMID 37111667, PMCID PMC10143057.
Al Hanbali OA, Khan HM, Sarfraz M, Arafat M, Ijaz S, Hameed A. Transdermal patches: design and current approaches to painless drug delivery. Acta Pharm. 2019;69(2):197-215. doi: 10.2478/acph-2019-0016, PMID 31259729.
Rastogi V, Yadav P. Transdermal drug delivery system: an overview. Asian J Pharm. 2012;6(3):161-70. doi: 10.4103/0973-8398.104828.
Ramadon D, McCrudden MT, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758-91. doi: 10.1007/s13346-021-00909-6, PMID 33474709.
Vikrant A, Arya ML. A review on anti-inflammatory plant barks. Int J Pharm Tech Res. 2011;3(2):899-908.
Mathews LM. Management of pain using transdermal patches. Asian J Pharm Clin Res. 2016:9(6):32-5. doi: 10.22159/ajpcr.2016.v9i6.13775.
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-8. doi: 10.1038/nbt.1504, PMID 18997767.
Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56(5):619-58. doi: 10.1016/j.addr.2003.10.026, PMID 15019750.
Branvold A. Pain management therapy: the benefits of compounded transdermal pain medication. J Gen Pract. 2014;02(6):1000188. doi: 10.4172/2329-9126.1000188.
Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115-24. doi: 10.1038/nrd1304, PMID 15040576.
Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23(2):564-78. doi: 10.3109/10717544.2014.935532, PMID 25006687.
Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23-33. doi: 10.2174/1567201052772915, PMID 16305405.
Chen Y, Quan P, Liu X, Wang M, Fang L. Novel chemical permeation enhancers for transdermal drug delivery. Asian J Pharm Sci. 2014;9(2):51-64. doi: 10.1016/j.ajps.2014.01.001.
Ghasemiyeh P, Mohammadi Samani S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des Devel Ther. 2020;14:3271-89. doi: 10.2147/DDDT.S264648, PMID 32848366.
Gao Y, DU L, LI Q, LI Q, Zhu L, Yang M. How physical techniques improve the transdermal permeation of therapeutics: a review. Medicine (Baltimore). 2022;101(26):e29314. doi: 10.1097/MD.0000000000029314, PMID 35777055.
Ahsan A, Tian WX, Farooq MA, Khan DH. An overview of hydrogels and their role in transdermal drug delivery. Int J Polym Mater Polym Biomater. 2021;70(8):574-84. doi: 10.1080/00914037.2020.1740989.
Gupta MM, Singh S, Jindal R, Patidar S. Role in transdermal drug delivery system skin : a barrier permeation for. International Journal of Comprehensive Pharmacy Penetration Enhancers. 2012;03(9):1-8.
Cyclodextrins in delivery systems: applications scientific fig. On ResearchGate. Available from: https://www.researchgate.net/figure/cyclodextrins-in-transdermal-drug-delivery-system_tbl4_51545265. [Last accessed on 06 Jun 2024].
Published
How to Cite
Issue
Section
Copyright (c) 2024 PRACHI SHARMA, Dr. Ashish Aggarwal, SHUBHAM TANDON
This work is licensed under a Creative Commons Attribution 4.0 International License.